Perspective Therapeutics Inc (CATX) returns
Perspective Therapeutics returns over 10 years
$1,000 invested in Perspective Therapeutics ten years ago was worth $188.53 at the close on October 30, 2026, with dividends reinvested: an average return of -15.4% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -58.2% | — | $418.18 | -0.9% |
| 3 months | -61.5% | — | $384.62 | +2.1% |
| Year to date | -58.2% | — | $418.18 | +11.7% |
| 1 year | -56.4% | — | $435.61 | +12.4% |
| 3 years | -55.4% | -23.6% | $446.25 | +88.5% |
| 5 years | -81.0% | -28.3% | $190.08 | +76.0% |
| 10 years | -81.1% | -15.4% | $188.53 | +316.6% |
Perspective Therapeutics return by calendar year
| Year | CATX | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -58.2% | +11.7% | -69.9% |
| 2025 | -13.8% | +17.7% | -31.5% |
| 2024 | -20.6% | +24.9% | -45.5% |
| 2023 | +62.7% | +26.2% | +36.5% |
| 2022 | -36.3% | -18.2% | -18.1% |
| 2021 | -13.8% | +28.7% | -42.6% |
| 2020 | -27.4% | +18.4% | -45.8% |
| 2019 | +106.7% | +31.2% | +75.4% |
| 2018 | -25.0% | -4.6% | -20.4% |
| 2017 | -31.0% | +21.7% | -52.7% |
| 2016 | -38.1% | +12.0% | -50.1% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: CATX financials
No forecast, no recommendation. This page describes Perspective Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.